Annual Total Liabilities
$293.90 M
+$27.04 M+10.13%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual total liabilities is currently $293.90 million, with the most recent change of +$27.04 million (+10.13%) on 31 December 2023. ZBIO annual total liabilities is now at all-time high.ZBIO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$44.00 M
-$444.74 M-91.00%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly total liabilities is currently $44.00 million, with the most recent change of -$444.74 million (-91.00%) on 30 September 2024. Over the past year, it has dropped by -$242.03 million (-84.62%). ZBIO quarterly total liabilities is now -91.00% below its all-time high of $488.73 million, reached on 30 June 2024.ZBIO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.1% | -84.6% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ZBIO Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +10.1% | -91.0% | at low |
| 5 y | 5 years | at high | +10.1% | -91.0% | at low |
| alltime | all time | at high | +10.1% | -91.0% | at low |
ProShares UltraPro Short Nasdaq Biotechnology Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $44.00 M(-91.0%) |
| June 2024 | - | $488.73 M(+62.1%) |
| Mar 2024 | - | $301.55 M(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $293.90 M(+10.1%) | $293.90 M(+2.8%) |
| Sept 2023 | - | $286.02 M |
| Dec 2022 | $266.87 M | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual total liabilities?
- What is the all time high annual total liabilities for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology annual total liabilities year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total liabilities?
- What is the all time high quarterly total liabilities for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total liabilities year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual total liabilities?
The current annual total liabilities of ZBIO is $293.90 M
What is the all time high annual total liabilities for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual total liabilities is $293.90 M
What is ProShares UltraPro Short Nasdaq Biotechnology annual total liabilities year-on-year change?
Over the past year, ZBIO annual total liabilities has changed by +$27.04 M (+10.13%)
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total liabilities?
The current quarterly total liabilities of ZBIO is $44.00 M
What is the all time high quarterly total liabilities for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly total liabilities is $488.73 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total liabilities year-on-year change?
Over the past year, ZBIO quarterly total liabilities has changed by -$242.03 M (-84.62%)